Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces

Antibody-mediated delivery of immunogenic viral CD8+ T-cell epitopes to redirect virus-specific T cells toward cancer cells is a promising new therapeutic avenue to increase the immunogenicity of tumors. Multiple strategies for viral epitope delivery have been shown to be effective. So far, most of...

Full description

Saved in:
Bibliographic Details
Main Authors: W. van der Wulp, W. Luu, M. E. Ressing, J. Schuurman, S. I. van Kasteren, L. Guelen, R. C. Hoeben, B. Bleijlevens, M. H. M. Heemskerk
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:mAbs
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2024.2329321
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576572761047040
author W. van der Wulp
W. Luu
M. E. Ressing
J. Schuurman
S. I. van Kasteren
L. Guelen
R. C. Hoeben
B. Bleijlevens
M. H. M. Heemskerk
author_facet W. van der Wulp
W. Luu
M. E. Ressing
J. Schuurman
S. I. van Kasteren
L. Guelen
R. C. Hoeben
B. Bleijlevens
M. H. M. Heemskerk
author_sort W. van der Wulp
collection DOAJ
description Antibody-mediated delivery of immunogenic viral CD8+ T-cell epitopes to redirect virus-specific T cells toward cancer cells is a promising new therapeutic avenue to increase the immunogenicity of tumors. Multiple strategies for viral epitope delivery have been shown to be effective. So far, most of these have relied on a free C-terminus of the immunogenic epitope for extracellular delivery. Here, we demonstrate that antibody-epitope conjugates (AECs) with genetically fused epitopes to the N-terminus of the antibody can also sensitize tumors for attack by virus-specific CD8+ T cells. AECs carrying epitopes genetically fused at the N-terminus of the light chains of cetuximab and trastuzumab demonstrate an even more efficient delivery of the T-cell epitopes compared to AECs with the epitope fused to the C-terminus of the heavy chain. We demonstrate that this increased efficiency is not caused by the shift in location of the cleavage site from the N- to the C-terminus, but by its increased proximity to the cell surface. We hypothesize that this facilitates more efficient epitope delivery. These findings not only provide additional insights into the mechanism of action of AECs but also broaden the possibilities for genetically fused AECs as an avenue for the redirection of multiple virus-specific T cells toward tumors.
format Article
id doaj-art-c04c265bd991403696916acc78b8076a
institution Kabale University
issn 1942-0862
1942-0870
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series mAbs
spelling doaj-art-c04c265bd991403696916acc78b8076a2025-01-31T04:19:38ZengTaylor & Francis GroupmAbs1942-08621942-08702024-12-0116110.1080/19420862.2024.2329321Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfacesW. van der Wulp0W. Luu1M. E. Ressing2J. Schuurman3S. I. van Kasteren4L. Guelen5R. C. Hoeben6B. Bleijlevens7M. H. M. Heemskerk8Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The NetherlandsGenmab, Utrecht, The NetherlandsDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The NetherlandsGenmab, Utrecht, The NetherlandsDivision of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden, The NetherlandsGenmab, Utrecht, The NetherlandsDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The NetherlandsGenmab, Utrecht, The NetherlandsDepartment of Hematology, Leiden University Medical Center, Leiden, The NetherlandsAntibody-mediated delivery of immunogenic viral CD8+ T-cell epitopes to redirect virus-specific T cells toward cancer cells is a promising new therapeutic avenue to increase the immunogenicity of tumors. Multiple strategies for viral epitope delivery have been shown to be effective. So far, most of these have relied on a free C-terminus of the immunogenic epitope for extracellular delivery. Here, we demonstrate that antibody-epitope conjugates (AECs) with genetically fused epitopes to the N-terminus of the antibody can also sensitize tumors for attack by virus-specific CD8+ T cells. AECs carrying epitopes genetically fused at the N-terminus of the light chains of cetuximab and trastuzumab demonstrate an even more efficient delivery of the T-cell epitopes compared to AECs with the epitope fused to the C-terminus of the heavy chain. We demonstrate that this increased efficiency is not caused by the shift in location of the cleavage site from the N- to the C-terminus, but by its increased proximity to the cell surface. We hypothesize that this facilitates more efficient epitope delivery. These findings not only provide additional insights into the mechanism of action of AECs but also broaden the possibilities for genetically fused AECs as an avenue for the redirection of multiple virus-specific T cells toward tumors.https://www.tandfonline.com/doi/10.1080/19420862.2024.2329321antibody-epitope conjugates (AECs)virus-specific T-cellsimmunotherapyredirecting T-cellsbispecific-antibodies
spellingShingle W. van der Wulp
W. Luu
M. E. Ressing
J. Schuurman
S. I. van Kasteren
L. Guelen
R. C. Hoeben
B. Bleijlevens
M. H. M. Heemskerk
Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
mAbs
antibody-epitope conjugates (AECs)
virus-specific T-cells
immunotherapy
redirecting T-cells
bispecific-antibodies
title Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
title_full Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
title_fullStr Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
title_full_unstemmed Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
title_short Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
title_sort antibody epitope conjugates deliver immunogenic t cell epitopes more efficiently when close to cell surfaces
topic antibody-epitope conjugates (AECs)
virus-specific T-cells
immunotherapy
redirecting T-cells
bispecific-antibodies
url https://www.tandfonline.com/doi/10.1080/19420862.2024.2329321
work_keys_str_mv AT wvanderwulp antibodyepitopeconjugatesdeliverimmunogenictcellepitopesmoreefficientlywhenclosetocellsurfaces
AT wluu antibodyepitopeconjugatesdeliverimmunogenictcellepitopesmoreefficientlywhenclosetocellsurfaces
AT meressing antibodyepitopeconjugatesdeliverimmunogenictcellepitopesmoreefficientlywhenclosetocellsurfaces
AT jschuurman antibodyepitopeconjugatesdeliverimmunogenictcellepitopesmoreefficientlywhenclosetocellsurfaces
AT sivankasteren antibodyepitopeconjugatesdeliverimmunogenictcellepitopesmoreefficientlywhenclosetocellsurfaces
AT lguelen antibodyepitopeconjugatesdeliverimmunogenictcellepitopesmoreefficientlywhenclosetocellsurfaces
AT rchoeben antibodyepitopeconjugatesdeliverimmunogenictcellepitopesmoreefficientlywhenclosetocellsurfaces
AT bbleijlevens antibodyepitopeconjugatesdeliverimmunogenictcellepitopesmoreefficientlywhenclosetocellsurfaces
AT mhmheemskerk antibodyepitopeconjugatesdeliverimmunogenictcellepitopesmoreefficientlywhenclosetocellsurfaces